Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (1): 85-91.
DOI: 10.19803/j.1672-8629.20220356
Previous Articles Next Articles
FU Xiaotong, LIU Ting, CAO Chunyu, ZHANG Haijing, XIA Bing, ZHAO Xiao'ang, WANG Lifang, ZHAO Chunhui, YANG Yifei*
Received:
2022-06-28
Published:
2023-01-19
CLC Number:
FU Xiaotong, LIU Ting, CAO Chunyu, ZHANG Haijing, XIA Bing, ZHAO Xiao'ang, WANG Lifang, ZHAO Chunhui, YANG Yifei. Liver injury induced by tripterygium glycosides based on P450 enzymes and toxicity reduction of compound glycyrrhizin[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 85-91.
[1] KANG BY, ZHAO XT, YANG YL, et al.Pharmacological action and clinical application of leigongteng(tripterygium wilfordii)[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2021, 39(6): 102-106. [2] JIANG M, ZHANG HB, DING Y, et al.Research progress on pharmacological activities and clinical applications of tripterygium glycosides[J]. Chinese Archives of Traditional Chinese Medicine(中华中医药学刊), 2021, 39(3): 59-63. [3] ZHU F, GUO DH, YUAN FY, et al.Evaluation and analysis of 5188 cases of possible ADR reports caused by traditional Chinese medicine from 123 hospitals[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2015, 12(2): 94-97. [4] National Medical Products Administration. Adverse drug reaction information bulletin(No. 46) concerned about the safety of tripterygium wilfordii preparations [EB/OL]. (2012-04-01) [2022-06-02]. https://www.nmpa.gov.cn/xxgk/yjjsh/ypblfytb/20120401101301366.html. [5] YIN CX.Literature analysis of 55 cases of adverse drug reaction by glucoside tripterygium total[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2013, 10(8): 478-482. [6] PU W, ZHOU Y,YUAN XP, et al.Clinical study of tripterygium wilfordii polyglycoside combined with compound glycyrrhizin in the treatment of eczema[J]. Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine(中国中西医结合皮肤性病学杂志), 2018, 17(2): 143-145. [7] WANG H.Clinical observation of tripterygium wilfordii glycosides combined with compound glycyrrhizin in the treatment of psoriasis vulgaris[J]. The Journal of Medical Theory and Practice(医学理论与实践), 2017, 30(8): 1178-1180. [8] DAI Y,WANG QW,HE S, et al.Analysis of curative effect of Tripterygium wilfordii polyglycoside combined with compound glycyrrhizin in treating 49 cases of allergic purpura in children[J]. Chinese Journal of Postgraduates of Medicine(中国医师进修杂志), 2012, 35(6): 67-68. [9] MA ZJ,ZHANG CN,TANG JF, et al.Study of metabolic pathway of Radix glycyrrhiza in decreasing liver toxicity of Tripterygium wilfordii[J]. Acta Pharmaceutica Sinica(药学学报), 2017, 52(7): 1077-1084. [10] ELFAKI I, RASHID M, ALMUTAF M, et al.Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis[J]. Asian Pacific Journal of Cancer Prevention : APJCP, 2018, 19(8):2057-2070. [11] MANIKANDAN P, SIDDAVARAM N.Cytochrome P450 structure, function and clinical significance: a review[J]. Current Drug Targets, 2018, 19(1):38-54. [12] ZHAO XM,PU SB,ZHAO QG, et al.Preliminary study on effective components of Tripterygium wilfordii for liver toxicity based on spectrum-effect correlation analysis[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(15): 2915-2921. [13] LYU M,DENG J, TANG N, et al.Efficacy and safety of tripterygium wilfordii hook f on psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials[J]. Evidence-based complementary and alternative medicine : eCAM, 2018(4):2623085. [14] FANG H,ZHANG XH,ZHANG CJ, et al.Clinical curative effect of tripterygium polyglycoside combined with cozaar in elderly patients with lgA nephropathy and its influence on expression of TGFβ1,PAI-1 and VEGF[J]. Chongqing Medicine(重庆医学), 2017, 46(21): 2937-2939. [15] LI YQ,HU RX,JIA KX, et al.[J]. Meta-analysis on safety of tripterygium glycosides tablets in treatment of rheumatoid arthritis[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(4): 775-790. [16] LIANG DN, HANWEN M, FANGYI R, et al.The efficacy of triptolide in preventing diabetic kidney diseases: a systematic review and meta-analysis[J]. Frontiers in Pharmacology, 2021, 12:728758. [17] KAI Y, LI XH, LU QY, et al.Applicati and mechanisms of triptolide in the treatment of inflammatory diseases-a review[J]. Frontiers in pharmacology, 2019, 10:1469. [18] LI XX, DU FY, LIU HX, et al.Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity[J]. Journal of Ethnopharmacology, 2015, 162: 238-243. [19] PENG C, XIAO XH, LI S, et al.Research progress and frontier analysis of integrated analysis of toxicity and efficacy in Traditional Chinese medicine[J]. Bulletin of National Natural Science Foundation of China(中国科学基金), 2017, 31(2): 176-183. [20] YU LC,MAO YM,CHEN CW.Guidelines for diagnosis and treatment of drug-induced liver injury[J]. Journal of Practical Hepatology(实用肝脏病杂志), 2017, 20(2): 257-274. [21] LI L, JIANG ZZ, LIU J, et al.Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats[J]. Toxicology, 2010, 271(1-2): 57-63. [22] SHI QL, WANG QX, CHEN JY, et al.Transcriptome and lipid metabolomics-based discovery: glycyrrhizic acid alleviates tripterygium glycoside tablet-induced acute liver injury by regulating the activities of cyp and the metabolism of phosphoglycerides[J]. Frontiers in Pharmacology, 2022, 12:822154. [23] HUANG XT,XIAO RM,WU YX, et al.In vivo effect of arecoline hydrobromide on rat hepatic CvmOB expression and its mechanism[J]. Chinese Traditional and Herbal Drugs(中草药), 2016, 47(20): 3668-3672. [24] ZHANG GY, ZHANGYP, MA XJ, et al.Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1 [25] XU YE, ZHANG YF, CHEN XY, et al.CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats[J]. Acta pharmacologica Sinica, 2018, 39(8): 1386-1392. [26] GUOLIN S, ZHUANG XM, XIAO WB, et al.Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes[J]. Food and Chemical Toxicology, 2014, 71:90-96. [27] XIAO CY, LI WY, YAN Y, et al.Effects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in rat[J]. Toxicology Letters, 2010, 192(2): 212-220. [28] WANG QX, LEI RH, WU QC, et al.Induction of cytochrome P450 enzymes by emodin in liver tissue of rats[J]. Drug Evaluation Research, 2015, 38(2): 147-150. [29] SCHUETZ-E G.Induction of cytochromes P450[J]. Current Drug Metabolism, 2001, 2(2):205. [30] WANG YD, WANG Q, ZHANG JB, et al, Research progress on chemical constituents and quality control of Tripterygium wilfordii preparations[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2019, 44(16): 3368-3373. [31] YU X, LI XB, HE XJ, et al.The mechanisms of drug induced liver injury[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2017, 37(10): 895-899. [32] HOU J,SUN E,SONG J,et al.Relationship between hepatic drug-metabolizing enzymes CYP450 and traditional Chinese medicine-induced hepatotoxicity[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(15): 2774-2780. [33] ZHANG J, JIANG Y, WANG F, et al.Detoxicity effect of hepatotoxicity of Tripterygium wilfordii by compatibility mechanism based on“diversity restriction”theory[J]. Chinese Traditional and Herbal Drugs(中草药), 2014, 45(18): 2711-2715. [34] WANG XY, LI WX, ZHANG H, et al.Meta–analysis on effectiveness and safety of compound glycyrrhizin for drug – induced liver injury[J]. Journal of Practical Traditional Chinese Internal Medicine(实用中医内科杂志), 2021, 35(1): 22-27. [35] HE W, NING J, WU JJ, et al.Research progress in interaction between chemical components of Glycyrrhizae Radix and cytochrome P450 enzyme[J]. Chinese Traditional and Herbal Drugs(中草药), 2016, 47(11): 1974-1981. [36] TING T, HUANG X, SU YW, et al.Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats[J]. Journal of Ethnopharmacology, 2014, 152(2): 358-363. [37] WEI H, LIU B, XU HT.Triptolide: medicinal chemistry, chemical biology and clinical progress[J]. European Journal of Medicinal Chemistry, 2019, 176 : 378-392. |
[1] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[2] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[3] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[4] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[5] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[6] | QI Yujie, WANG Xin, ZHANG Jiahui, MA Enlong, GENG Xingchao. Research Progress in Integration Sites for Cellular and Gene Therapy Products [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 721-727. |
[7] | LI Qiurong, FU Miaoqing, ZHOU Baishui, LI Cui, XIAO Xiaotong, YU Yuping, DENG Lu. Mining of Real-World ADR Signals Related to Cefradine for Injection in 268 Cases [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 790-793. |
[8] | LI Ying, HUANG Lishuang, ZHANG Jingjing, ZHU Yuanchao, SHEN Ji, YANG Jun. Pharmaceutical Care to a Geriatric Syndrome Patient with Heart Failure Combined with Uremia [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 805-808. |
[9] | LIN Lu, ZHAO Anzhi, CHEN Jinhui, LI Zhongwen, HUANG Guohua, ZHONG Shilong. One Case of Delayed Hypersensitivity Reactions Caused by Cefotaxime Sodium and Sulbactam Sodium for Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 809-811. |
[10] | HU Haipeng, YAO Weijie, FENG Xin. Effects of Yangxue Antai Prescription on Placental Ferroptosis in Recurrent Spontaneous Abortion Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 621-626. |
[11] | FU Rui, LUO Qian, PENG Bo, CHEN Weiya, WEI Xiaolu, CHEN Tengfei, SONG Ling, GAO Yunhang, ZHANG Guangping, HOU Hongping. Efficacy of Tanreqing Aerosol Inhalation against Animals with Chronic Obstructive Pulmonary Disease and Mechanisms for Oxidative Stress and Mitochondrial Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 627-632. |
[12] | ZHENG Sili, ZHANG Xiaoqing. 133 Cases of Adverse Drug Reactions in Female Patients [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 654-658. |
[13] | WANG Hao, MA Jinfu, MA Rui, LI Xiaogang, ZHAO Qiang, ZHANG Xian. One Case of Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium for Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 686-688. |
[14] | LU Jing, CAI Lei, TONG Fei, YU Changhui, FU Shunjun, PAN Mingxin. One Case of Ischemic Colitis Caused by Compound Polyethylene Glycol Electrolyte Powder [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 699-701. |
[15] | ZHAO Ronghua, ZHU Chunxu, SUN Jing, BAO Lei, WANG Xinwei, GENG Zihan, ZHANG Jingsheng, GUO Shanshan, LI Shuran, WANG Daohan, CUI Xiaolan. Mechanisms of Sanhan Huashi Granules on a Respiratory Syncytial Virus and Influenza Virus and Respiratory Syncytial Virus Induced Pneumonia Model in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 488-494. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||